ABT vs POST · P/E 25, rev $44.33B vs P/E 15, rev $8.16B
Abbott Laboratories (ABT) versus Post Holdings Inc (POST) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Post Holdings Inc (POST) is a packaged foods company listed on NYSE.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported POST revenue for 2025-09-30 was $8.16B. Net income was $335.8M. Revenue was up 3.0% from 2024-09-30 to 2025-09-30. POST currently screens at market cap $4.03B and trailing P/E 14.9.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. POST currently screens at market cap $4.03B and trailing P/E 14.9.
Not investment advice. Open the ABT and POST stock pages for the full models.
Not investment advice.